These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27398828)

  • 1. Feasibility of clinical psychosocial screening in pediatric oncology: Implementing the PAT2.0.
    McCarthy MC; Wakefield CE; DeGraves S; Bowden M; Eyles D; Williams LK
    J Psychosoc Oncol; 2016; 34(5):363-75. PubMed ID: 27398828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of family psychosocial functioning in survivors of pediatric cancer using the PAT2.0.
    Gilleland J; Reed-Knight B; Brand S; Griffin A; Wasilewski-Masker K; Meacham L; Mertens A
    Psychooncology; 2013 Sep; 22(9):2133-9. PubMed ID: 23529924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived benefits of and barriers to psychosocial risk screening in pediatric oncology by health care providers.
    Barrera M; Alexander S; Shama W; Mills D; Desjardins L; Hancock K
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27429. PubMed ID: 30160072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring psychosocial risk in families caring for a child with cancer: the Psychosocial Assessment Tool (PAT2.0).
    McCarthy MC; Clarke NE; Vance A; Ashley DM; Heath JA; Anderson VA
    Pediatr Blood Cancer; 2009 Jul; 53(1):78-83. PubMed ID: 19343796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Providers' Perceptions of the Utility of Psychosocial Screening Tools in Childhood Cancer: A Pilot Study.
    Di Battista A; Hancock K; Cataudella D; Johnston D; Cassidy M; Punnett A; Shama W; Barrera M
    Oncol Nurs Forum; 2015 Jul; 42(4):391-7. PubMed ID: 26148318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of psychosocial screening and service provision in pediatric oncology: the Psychosocial Assessment Tool (PAT2.0) into clinical practice.
    McCarthy MC; DeGraves S; Wakefield CE; Bowden MJ; Marks LV; Williams LK
    Support Care Cancer; 2016 Jul; 24(7):2945-52. PubMed ID: 26857925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Psychosocial Assessment Tool (PAT2.0): psychometric properties of a screener for psychosocial distress in families of children newly diagnosed with cancer.
    Pai AL; Patiño-Fernández AM; McSherry M; Beele D; Alderfer MA; Reilly AT; Hwang WT; Kazak AE
    J Pediatr Psychol; 2008; 33(1):50-62. PubMed ID: 17609228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for psychosocial distress: a national survey of oncology social workers.
    BrintzenhofeSzoc K; Davis C; Kayser K; Lee HY; Nedjat-Haiem F; Oktay JS; Zabora J; Zebrack BJ
    J Psychosoc Oncol; 2015; 33(1):34-47. PubMed ID: 25420574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider Perspectives on the Implementation of Psychosocial Risk Screening in Pediatric Cancer.
    Kazak AE; Barakat LP; Askins MA; McCafferty M; Lattomus A; Ruppe N; Deatrick J
    J Pediatr Psychol; 2017 Jul; 42(6):700-710. PubMed ID: 28339637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months.
    Desjardins L; Etkin-Spigelman L; Hancock K; Chung J; Shama W; Mills D; Alexander S; Barrera M
    Support Care Cancer; 2020 Apr; 28(4):1717-1723. PubMed ID: 31292754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Families following pediatric traumatic medical events: identifying psychosocial risk profiles using latent profile analysis.
    Sadeh Y; Dekel R; Brezner A; Landa J; Silberg T
    Eur J Psychotraumatol; 2022; 13(2):2116825. PubMed ID: 36186160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrolment in paediatric oncology early-phase clinical trials: The health-care professionals' perspective.
    Robertson EG; Mitchell R; Wakefield CE; Lewis P; Cousens N; Marshall GM; Russell SJ; Ziegler DS; Anazodo AC; Trahair TN; Barbaric D; Cohn RJ; Alvaro F; O'Brien TA
    J Paediatr Child Health; 2019 May; 55(5):561-566. PubMed ID: 30288839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Psychosocial Risk in Dutch Families of a Child With Cancer: Reliability, Validity, and Usability of the Psychosocial Assessment Tool.
    Sint Nicolaas SM; Schepers SA; Hoogerbrugge PM; Caron HN; Kaspers GJ; van den Heuvel-Eibrink MM; Grootenhuis MA; Verhaak CM
    J Pediatr Psychol; 2016 Aug; 41(7):810-9. PubMed ID: 26715054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care providers' perspectives about working with parents of children with cancer: a qualitative study.
    Klassen A; Gulati S; Dix D
    J Pediatr Oncol Nurs; 2012; 29(2):92-7. PubMed ID: 22415857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing psychosocial risk in pediatric inflammatory bowel disease: validation of the Psychosocial Assessment Tool 2.0_General.
    Pai AL; Tackett A; Hente EA; Ernst MM; Denson LA; Hommel KA
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):51-6. PubMed ID: 23969535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demands and rewards associated with working in pediatric oncology: a qualitative study of Canadian health care providers.
    Dix D; Gulati S; Robinson P; Syed I; Klassen A
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):430-5. PubMed ID: 22767131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to Palliative Care in Pediatric Oncology in Switzerland: A Focus Group Study.
    Rost M; De Clercq E; Rakic M; Wangmo T; Elger B
    J Pediatr Oncol Nurs; 2020; 37(1):35-45. PubMed ID: 31478463
    [No Abstract]   [Full Text] [Related]  

  • 18. Distress screening: experiences of oncology social workers.
    Oktay JS; Nedjat-Haiem FR; Davis C; Kern KC
    J Psychosoc Oncol; 2012; 30(6):652-66. PubMed ID: 23101549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for psychosocial risk at pediatric cancer diagnosis: the psychosocial assessment tool.
    Kazak AE; Barakat LP; Ditaranto S; Biros D; Hwang WT; Beele D; Kersun L; Alderfer MA; Mougianis I; Hocking MC; Reilly A
    J Pediatr Hematol Oncol; 2011 May; 33(4):289-94. PubMed ID: 21516024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial Assessment Tool 2.0_General: validity of a psychosocial risk screener in a pediatric kidney transplant sample.
    Pai AL; Tackett A; Ittenbach RF; Goebel J
    Pediatr Transplant; 2012 Feb; 16(1):92-8. PubMed ID: 22192481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.